Suppr超能文献

在胰腺腺癌的背景下分离细胞外囊泡:增加一个严格的过滤步骤可提高特定 microRNAs 的回收率。

Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.

机构信息

Department of Pathology, Stephenson Cancer Centre, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.

Department of General Surgery, First People's Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, Suzhou, China.

出版信息

PLoS One. 2021 Nov 16;16(11):e0259563. doi: 10.1371/journal.pone.0259563. eCollection 2021.

Abstract

microRNAs (miRNA) in extracellular vesicles (EVs) have been investigated as potential biomarkers for pancreatic ductal adenocarcinoma (PDAC). However, a mixed population of EVs is often obtained using conventional exosome isolation methods for biomarker development. EVs are derived from different cellular processes and present in various sizes, therefore miRNA expression among them is undoubtedly different. We developed a simple protocol utilizing sequential filtration and ultracentrifugation to separate PDAC EVs into three groups, one with an average diameter of more than 220 nm, named operational 3 (OP3); one with average diameters between 100-220 nm, named operational 2 (OP2); and another with average diameters around 100 nm, named operational 1 (OP1)). EVs were isolated from conditioned cell culture media and plasma of human PDAC xenograft mice and early stage PDAC patients, and verified by nanoparticle tracking, western blot, and electronic microscopy. We demonstrate that exosome specific markers are only enriched in the OP1 group. qRT-PCR analysis of miRNA expression in EVs from PDAC cells revealed that expression of miR-196a and miR-1246, two previously identified miRNAs highly enriched in PDAC cell-derived exosomes, is significantly elevated in the OP1 group relative to the other EV groups. This was confirmed using plasma EVs from PDAC xenograft mice and patients with localized PDAC. Our results indicate that OP1 can be utilized for the identification of circulating EV miRNA signatures as potential biomarkers for PDAC.

摘要

细胞外囊泡 (EVs) 中的 microRNAs (miRNA) 已被研究作为胰腺导管腺癌 (PDAC) 的潜在生物标志物。然而,使用传统的外泌体分离方法开发生物标志物时,通常会获得混合的 EV 群体。EV 来源于不同的细胞过程,并以不同的大小存在,因此其中的 miRNA 表达无疑是不同的。我们开发了一种简单的方案,利用连续过滤和超速离心将 PDAC EV 分离成三组,一组平均直径大于 220nm,命名为操作 3 (OP3);一组平均直径在 100-220nm 之间,命名为操作 2 (OP2);另一组平均直径约为 100nm,命名为操作 1 (OP1)。从人胰腺导管腺癌异种移植小鼠和早期 PDAC 患者的条件细胞培养培养基和血浆中分离 EVs,并通过纳米颗粒跟踪、western blot 和电子显微镜进行验证。我们证明,外泌体特异性标志物仅在 OP1 组中富集。对来自 PDAC 细胞的 EVs 中的 miRNA 表达进行 qRT-PCR 分析表明,miR-196a 和 miR-1246 的表达水平显著升高,这两种 miRNA 先前被鉴定为高度富集在 PDAC 细胞衍生的外泌体中。在 PDAC 异种移植小鼠的血浆 EVs 和局部 PDAC 患者中得到了证实。我们的结果表明,OP1 可用于鉴定循环 EV miRNA 特征作为 PDAC 的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/8594802/820127284229/pone.0259563.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验